News and Insights
From the Medical Affairs Experts at Zipher
November 2021
The Value of Insights
Insights provide the ability to gain a clear, deep, and sometimes unexpected understanding of a complicated problem or situation. In the pharmaceutical arena, insights are external trends that are actionable and have the potential to alter medical strategy
Medical Affairs Unscripted Episode 9 Now Available
Host Peg Crowley-Nowick, PhD, MBA, Founder & President of Zipher Medical Affairs and Murial Siadak, PAC, spotlight the ever-increasing value and impact of insights on product strategy, positioning, and tactics.
October 2021
Five Things to Consider for Effective PM Tracking Systems
An effective program management system with well-designed project trackers, dashboards and project management support can accelerate your launch strategy.
September 2021
Medical Affairs Unscripted Episode 8 Now Available
Drs. Crowley-Nowick and Keir set the stage for a successful launch as they consider the key components of a MA Team and their contributions on the road to launch and beyond, from the formation and training of the Medical Science Liaison Team (MSLs) to the early inclusion of Medical Information, to developing best practices for Scientific Communications while also engaging with Patient Advocacy groups as part of the planning process.
July 2021
Medical Affairs Unscripted Episode 7 Now Available
Starting from the clinical trials and ending with meeting the regulatory demands across various countries, bringing a product to market successfully has become increasingly difficult. Therefore, it is critical that an overall launch strategy is established and executed.
May 2021
Medical Affairs Unscripted Episode 6 Now Available
Measuring the impact of the Medical Affairs (MA) organization is not as straightforward as it is for other functions (e.g., increase in revenue or market share for Commercial) and remains a challenge for most pharmaceutical companies today.
